No Data
No Data
Do Options Traders Know Something About DMC Global (BOOM) Stock We Don't?
De Motu Cordis (DMC) Applauds ARS Pharma's FDA Approval of Neffy, Expanding Patient Options to Needle-Free Epinephrine Delivery and Inspiring Confidence in Our Own Development Efforts
DMC Global (BOOM) Receives a Buy From Roth MKM
DMC Global Is Maintained at Buy by Stifel
Stifel Maintains DMC Global(BOOM.US) With Buy Rating, Cuts Target Price to $19
Stifel analyst Stephen Gengaro maintains $DMC Global(BOOM.US)$ with a buy rating, and adjusts the target price from $24 to $19.According to TipRanks data, the analyst has a success rate of 40.3% and
Express News | DMC Global Inc : Stifel Cuts Target Price to $19 From $24